Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript

Elevance Health, Inc. ( ELV ) Q2 2026 Earnings Call July 15, 2026 8:30 AM EDT Company Participants Nathan Rich - Vice President of Investor Relations Gail Boudreaux - President, CEO & Director Mark Kaye - Executive VP & CFO Felicia Norwood - Executive VP & Chief Health Benefits Officer Aimee Dailey - President of Government Business Morgan Kendrick Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Justin Lake - Wolfe Research, LLC Stephen Baxter - Wells Fargo Securities, LLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Lance Wilkes - Bernstein Institutional Services LLC, Research Division Lisa Gill - JPMorgan Chase & Co, Research Division Kevin Fischbeck - BofA Securities, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division David Windley - Jefferies LLC, Research Division Ryan Langston - TD Cowen, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division George Hill - Deutsche Bank AG, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead. Nathan Rich Vice President of Investor Relations Good morning, and welcome to Elevance Health's Second Quarter 2026 Earnings Conference Call. My name is Nathan Rich, Vice President of Investor Relations. With us on the earnings call are Gail Boudreaux, President and CEO; Mark Kaye, our CFO; Felicia Norwood, our Chief Health Benefits Officer; Morgan Kendrick, President of our Commercial Health Benefits business; and Aimee Dailey, President of our Government Health Benefits business. Gail will begin with a review of our second quarter results, the progress we have made against our